TVTX (STOCKS)
Travere Therapeutics, Inc. Common Stock
$30.620000
+1.660000 (+5.73%)
Prev close: $28.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric M. Dube
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,832.74M
- Employees
- 385
- P/E (TTM)
- -50.91
- P/B (TTM)
- 22.93
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $490.73M |
| Benefits Costs and Expenses | $540.00M |
| Cost Of Revenue | $10.34M |
| Costs And Expenses | $553.55M |
| Gross Profit | $480.39M |
| Nonoperating Income/Loss | $13.55M |
| Operating Expenses | $543.21M |
| Selling, General, and Administrative Expenses | $337.20M |
| Other Operating Expenses | $206.01M |
| Operating Income/Loss | -$62.82M |
| Income/Loss From Continuing Operations After Tax | -$50.26M |
| Income/Loss From Continuing Operations Before Tax | -$49.27M |
| Income/Loss From Discontinued Operations Net Of Tax | $24.72M |
| Income Tax Expense/Benefit | $988.00K |
| Income Tax Expense/Benefit, Current | $988.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$25.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$25.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$25.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.29 |
| Diluted Earnings Per Share | -$0.29 |
| Basic Average Shares | 89,211,813 |
| Diluted Average Shares | 89,211,813 |
| Assets | $605.19M |
| Current Assets | $437.57M |
| Inventory | $36.16M |
| Other Current Assets | $401.41M |
| Noncurrent Assets | $167.63M |
| Fixed Assets | $4.02M |
| Intangible Assets | $113.87M |
| Other Non-current Assets | $49.74M |
| Liabilities | $490.36M |
| Current Liabilities | $159.90M |
| Accounts Payable | $24.80M |
| Other Current Liabilities | $135.10M |
| Noncurrent Liabilities | $330.46M |
| Equity | $114.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $114.83M |
| Liabilities And Equity | $605.19M |
| Net Cash Flow From Operating Activities | $37.78M |
| Net Cash Flow From Operating Activities, Continuing | $37.78M |
| Net Cash Flow From Operating Activities, Discontinued | $0.00 |
| Net Cash Flow From Investing Activities | $27.89M |
| Net Cash Flow From Investing Activities, Continuing | $27.89M |
| Net Cash Flow From Investing Activities, Discontinued | $0.00 |
| Net Cash Flow From Financing Activities | -$33.47M |
| Net Cash Flow From Financing Activities, Continuing | -$33.47M |
| Net Cash Flow From Financing Activities, Discontinued | $0.00 |
| Exchange Gains/Losses | $2.29M |
| Net Cash Flow | $34.50M |
| Net Cash Flow, Continuing | $32.21M |
| Net Cash Flow, Discontinued | $0.00 |
| Comprehensive Income/Loss | -$26.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$26.66M |
| Other Comprehensive Income/Loss | -$26.66M |